{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T09:06:30Z","timestamp":1775552790449,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.hrthm.2010.12.016","type":"journal-article","created":{"date-parts":[[2010,12,14]],"date-time":"2010-12-14T05:42:58Z","timestamp":1292305378000},"page":"536-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Alan","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saman","family":"Nazarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Brinker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Tompkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Spragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles T.","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harikrishna","family":"Tandri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Marine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon F.","family":"Tomaselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald D.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles A.","family":"Henrikson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2010.12.016_bib1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/europace\/eul011","article-title":"Post-operative use of heparin increases morbidity of pacemaker implantation","volume":"8","author":"Marquie","year":"2006","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2010.12.016_bib2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1540-8159.2004.00441.x","article-title":"Pacemaker and implantable cardioverter defibrillator implantation without reversal of warfarin therapy","volume":"27","author":"Giudici","year":"2004","journal-title":"PACE"},{"key":"10.1016\/j.hrthm.2010.12.016_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinternmed.2007.23","article-title":"Risk of thromboembolism with short-term interruption of warfarin therapy","volume":"168","author":"Garcia","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.hrthm.2010.12.016_bib4","doi-asserted-by":"crossref","first-page":"299S","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2010.12.016_bib5","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0735-1097(00)00633-1","article-title":"A randomized trial comparing heparin initiation 6 h or 24 h after pacemaker or defibrillator implantation","volume":"35","author":"Michaud","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2010.12.016_bib6","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1540-8159.1998.tb00271.x","article-title":"Outpatient pacemaker procedures in orally anticoagulated patients","volume":"21","author":"Goldstein","year":"1998","journal-title":"PACE"},{"key":"10.1016\/j.hrthm.2010.12.016_bib7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1460-9592.2003.00084.x","article-title":"Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients","volume":"26","author":"Al-Khadra","year":"2003","journal-title":"PACE"},{"key":"10.1016\/j.hrthm.2010.12.016_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ahj.2009.06.005","article-title":"Implantation of cardiac rhythm devices without interruption of oral anticoagulation compared with perioperative bridging with low-molecular weight heparin","volume":"158","author":"Tischenko","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2010.12.016_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1540-8159.2009.02683.x","article-title":"Perioperative management of anticoagulation during device implantation\u2014The UK perspective","volume":"33","author":"De Bono","year":"2010","journal-title":"PACE"},{"key":"10.1016\/j.hrthm.2010.12.016_bib10","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.hrthm.2009.05.027","article-title":"Anticoagulation of patients on chronic warfarin undergoing arrhythmia device surgery: wide variability of perioperative bridging in Canada","volume":"6","author":"Krahn","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2010.12.016_bib11","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1016\/j.jacc.2009.12.056","article-title":"Dual antiplatelet therapy and heparin \u201cbridging\u201d significantly increase the risk of bleeding complications after pacemaker or implantable cardioverter-defibrillator device implantation","volume":"55","author":"Tompkins","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2010.12.016_bib12","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.hrthm.2010.02.018","article-title":"Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation","volume":"7","author":"Ahmed","year":"2010","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2010.12.016_bib13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1111\/j.1538-7836.2008.03080.x","article-title":"Perioperative anticoagulation in patients having implantation of a cardiac pacemaker or defibrillator: a systematic review and practical management guide","volume":"6","author":"Jamula","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.hrthm.2010.12.016_bib14","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1093\/eurheartj\/ehp194","article-title":"Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin?","volume":"30","author":"Tolosana","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2010.12.016_bib15","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199705223362107","article-title":"Management of anticoagulation before and after elective surgery","volume":"336","author":"Kearon","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2010.12.016_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0735-1097(03)00416-9","article-title":"AHA\/ACC Foundation guide to warfarin therapy","volume":"41","author":"Hirsh","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2010.12.016_bib17","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","article-title":"Guide to anticoagulant therapy","volume":"103","author":"Hirsh","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2010.12.016_bib18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1460-9592.2001.00456.x","article-title":"Prospective randomized comparison of the safety and effectiveness of placement of endocardial pacemaker and defibrillator leads using the extrathoracic subclavian vein guided by contrast venography versus the cephalic approach","volume":"24","author":"Calkins","year":"2001","journal-title":"PACE"},{"key":"10.1016\/j.hrthm.2010.12.016_bib19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1540-8159.2008.02247.x","article-title":"Postoperative low-molecular-weight heparin bridging is associated with an increase in wound hematoma following surgery for pacemakers and implantable defibrillators","volume":"32","author":"Robinson","year":"2009","journal-title":"PACE"},{"key":"10.1016\/j.hrthm.2010.12.016_bib20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0735-1097(89)90236-2","article-title":"Pacemaker-implantation complication rates: an analysis of some contributing factors","volume":"13","author":"Parsonnet","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2010.12.016_bib21","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jacc.2010.06.037","article-title":"Acute lead dislodgements and in-hospital mortality in patients enrolled in the NCDR ICD Registry","volume":"56","author":"Cheng","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2010.12.016_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1540-8159.2009.02674.x","article-title":"The relationship between warfarin, aspirin, and clopidogrel continuation in the peri-procedural period and the incidence of hematoma formation after device implantation","volume":"33","author":"Thal","year":"2010","journal-title":"PACE"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527110013809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527110013809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T06:43:22Z","timestamp":1761547402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527110013809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1547527110013809"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2010.12.016","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuation of warfarin during pacemaker or implantable cardioverter-defibrillator implantation: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2010.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}